An evidence-informed review of hormonal, menstrual and reproductive nutritional support
By Dr. Mehreen Faizan, Registered Pharmacist
XENRISE Healthcare Group of Companies / XENRISE Organica
Educational Research Article | 9 November 2026
Introduction: A Science-Led Approach to Women’s Wellness
Women’s hormonal and reproductive health is influenced by interconnected biological processes, including insulin signalling, ovarian function, nutritional status, cellular metabolism and overall lifestyle.
Because these systems are complex, no single supplement can be expected to correct every cause of menstrual irregularity, infertility or hormonal symptoms.
FOLAQ by XENRISE Organica is a multi-ingredient nutritional sachet combining myo-inositol, D-chiro-inositol, quercetin, vitamin E, coenzyme Q10 (CoQ10), vitamin D3 and vitamin B12.
This article reviews the biological roles of these ingredients, the quality of relevant research, and the distinction between nutritional support and proven treatment.
The available evidence for individual ingredients should not be interpreted as a clinical trial of the finished FOLAQ formulation.
Why Inositols Attract Scientific Interest
Myo-inositol and D-chiro-inositol are related naturally occurring compounds that participate in cellular signalling pathways.
They have attracted clinical research interest in polycystic ovary syndrome (PCOS), particularly because metabolic abnormalities and insulin resistance are common in many—but not all—people with PCOS.
The 2023 International Evidence-based Guideline for PCOS states that inositol in any form may be considered according to personal preferences and values, acknowledging potential improvements in some metabolic measures but limited demonstrated clinical benefits for outcomes such as ovulation, excess hair growth or weight.
Importantly, the guideline does not recommend a particular inositol form, ratio or dose because high-quality comparative evidence is lacking. [1]
A 2024 systematic review and meta-analysis prepared to inform that guideline concluded that evidence for inositol use in PCOS remains limited and inconclusive.
Study designs, formulations, doses and outcomes vary, which reduces certainty about how results apply to any individual product. [2]
What This Means for FOLAQ
FOLAQ supplies 1,100 mg myo-inositol and 150 mg D-chiro-inositol per sachet.
Its inositol combination can reasonably be described as part of a women’s metabolic and hormonal nutritional-support formula; however, the specific mixture has not been established here as superior to other ratios, and it must not be advertised as a proven PCOS treatment.
Menstrual-Cycle and Hormonal Wellbeing: What Is Known?
Menstrual-cycle patterns involve coordinated signalling between the brain, pituitary gland and ovaries, alongside thyroid function, nutrition and other health factors.
Some trials of inositol have examined menstrual regularity in women with PCOS, but the overall evidence base remains heterogeneous and often low-certainty.
Improvements reported in selected study groups should not be translated into promises of cycle regulation for all users. [1,2]
Persistent irregular periods, very heavy bleeding, severe pain or a new change in menstrual patterns deserve an appropriate medical assessment rather than reliance on a supplement alone.
Reproductive Wellness and Fertility: Important Evidence Limits
Interest in inositols and ovarian function has led to studies of ovulation and fertility-related outcomes.
However, the international PCOS guideline identifies inositol as an experimental fertility therapy for people with PCOS-associated infertility, because effects on ovulation, pregnancy and live birth remain uncertain. [1]
Therefore, FOLAQ should not be described as a fertility medicine, ovulation inducer, replacement for prescribed treatment, or a product guaranteed to support conception.
Women planning pregnancy or receiving fertility care should review every supplement with their clinician.
The Supporting Micronutrients and Antioxidants
Coenzyme Q10: Cellular Energy Biology
CoQ10 is naturally present in cells and participates in mitochondrial energy-production processes.
It has antioxidant-related biological functions; however, those mechanisms alone do not prove that a 25 mg supplement dose improves fertility, ovarian reserve or general energy in otherwise healthy women.
The US National Center for Complementary and Integrative Health notes that clinical evidence for many proposed CoQ10 benefits is insufficient and identifies potential medicine interactions. [3]
Vitamin E: Antioxidant Nutrition
Vitamin E is a fat-soluble nutrient with established antioxidant functions in the body.
FOLAQ lists 100 IU per sachet.
“IU” cannot be converted to a single milligram figure without knowing whether the ingredient is natural or synthetic alpha-tocopherol.
Vitamin E is not proven to correct hormonal imbalance; supplemental vitamin E can also interact with medicines affecting blood clotting. [4]
Vitamin D3: Bone and Muscle Health
Vitamin D contributes to calcium balance, normal bone health and muscle function.
FOLAQ declares 600 IU (15 micrograms) of vitamin D3 per sachet.
Whether vitamin D supplementation is needed depends on diet, sun exposure, health status and clinician assessment; evidence does not justify claiming that this dose specifically treats PCOS or menstrual disorders. [5]
Vitamin B12: Healthy Cellular Metabolism
Vitamin B12 supports normal red blood cell formation, neurological function and DNA synthesis, and is a cofactor in essential metabolic pathways.
FOLAQ provides 1.5 micrograms per sachet.
B12 may be important where dietary intake or absorption is insufficient; it is not a proven energy booster in people who already have adequate B12 status. [6]
Quercetin: An Emerging Research Ingredient
Quercetin is a plant-derived flavonoid studied for antioxidant and cell-signalling properties.
Biological plausibility and preliminary research should not be confused with established clinical benefits for menstrual health, PCOS or fertility.
The FOLAQ draft lists 600 mcg of quercetin per sachet; this unit must be verified against the approved label before publication.
FOLAQ Supplement Facts (Draft Label Transcription)
| Ingredient | Declared Amount Per Sachet |
|---|---|
| Myo-Inositol (BP) | 1,100 mg |
| D-Chiro Inositol (BP) | 150 mg |
| Quercetin (BP) | 600 mcg |
| Vitamin E (BP) | 100 IU |
| Coenzyme Q10 (BP) | 25 mg |
| Vitamin D3 (BP) | 600 IU |
| Vitamin B12 (BP) | 1.5 mcg |
Formulation Verification Notice:
All ingredient amounts above are supplied from the draft product information, not independently verified against a final approved label.
Who May Consider FOLAQ?
FOLAQ is positioned as nutritional support for adult women interested in an inositol-based, multi-nutrient wellness routine.
Selection should be individualized according to medical history, diet, existing medicines, pregnancy plans and professional advice.
It is not a substitute for diagnosis, dietary adequacy, physical activity, sleep or evidence-based medical care.
Directions and Precautions
Provisional Directions:
Mix one sachet in a glass of water or juice once daily, unless the approved pack label or a qualified healthcare professional directs otherwise.
The final website wording must match the approved label.
Important Precautions:
- Consult a healthcare professional before use during pregnancy, breastfeeding or pregnancy planning; while undergoing fertility treatment; or when managing PCOS, diabetes, thyroid disease or another ongoing condition.
- Discuss use with a pharmacist or clinician if taking regular medicines, especially anticoagulants or antiplatelet drugs, or medicines for blood glucose management. [3,4]
- Do not exceed the labelled recommended intake. Keep out of reach of children; store according to the final approved package instructions.
- If menstrual symptoms are persistent, severe or new, seek clinical evaluation rather than self-treating with supplements.
Conclusion: Responsible Science, Practical Nutritional Support
FOLAQ brings two forms of inositol together with selected vitamins and antioxidant-related nutrients in a convenient sachet.
Its ingredient choices reflect areas of active scientific interest in women’s wellness, but research strength varies widely across outcomes.
The most defensible public-health message is that FOLAQ can complement an individualized nutritional routine; it is not clinically established as a treatment for PCOS, infertility, insulin resistance or menstrual disorders.
Good women’s healthcare combines informed choice with realistic expectations.
Evidence-based information helps women and their healthcare teams decide whether a supplement fits their needs, while recognizing when medical evaluation or treatment is necessary.
Research References
[1] International Evidence-Based PCOS Guideline (2023)
Teede HJ, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
Human Reproduction. 2023;38(9):1655–1679.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10477934
[2] Inositol for Polycystic Ovary Syndrome (2024)
Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines.
Journal of Clinical Endocrinology & Metabolism. 2024.
https://pubmed.ncbi.nlm.nih.gov/38163998
[3] National Center for Complementary and Integrative Health (NCCIH)
Coenzyme Q10.
https://www.nccih.nih.gov/health/coenzyme-q10
[4] NIH Office of Dietary Supplements
Vitamin E: Fact Sheet for Health Professionals.
https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional
[5] NIH Office of Dietary Supplements
Vitamin D: Fact Sheet for Health Professionals.
https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional
[6] NIH Office of Dietary Supplements
Vitamin B12: Fact Sheet for Health Professionals.
https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional
Editorial and Medical Disclaimer
This is an educational, evidence-informed brand article, not an original clinical study or a systematic review conducted by the author.
It summarizes publicly available research on individual ingredients; no FOLAQ-specific randomized clinical trial is cited.
Scientific references are provided for transparency and do not imply endorsement of FOLAQ by the cited organizations.
This material does not replace personalized medical advice.
Article Author:
Dr. Mehreen Faizan
Registered Pharmacist
Published by:
XENRISE Healthcare Group of Companies
XENRISE Organica
Official Website: